ISSN: 2705-2214
Model: Open Access/Peer Reviewed
DOI: 10.31248/JPHD
Start Year: 2018
Email: jphd@integrityresjournals.org
https://doi.org/10.31248/JPHD2021.101 | Article Number: F137B8D42 | Vol.4 (5) - December 2021
Received Date: 11 May 2021 | Accepted Date: 08 October 2021 | Published Date: 30 December 2021
Authors: Luka, J. , Okeke, P. , Ombugadu, A. and Yina, G. I.*
Keywords: Control, endemic, lymphatic filariasis, MDA.
Lymphatic Filariasis (LF) is a neglected tropical disease (NTDs) that persists in developing countries causing disability through disfiguration with great economic repercussions. In Nigeria, LF is transmitted by female mosquitoes and caused by nematode, Wuchereria bancrofti. The vectors of LF, anopheles and culex mosquitoes, are widespread across rural and urban areas. This review focuses on the level of endemicity and control strategies employed against LF in Nigeria. Only reliable surveys are included in this review and criteria are applied to information identified through searches of published research in peer reviewed journals of electronic bibliographic and manual searches of local archives and libraries. Data are excluded if based on personal unpublished views. Two main strategies were employed for the control of LF as a public health problem in Nigeria, (i) interrupting transmission through annual large-scale treatment programmes, known as mass drug administration (MDA) of single doses of albendazole plus either diethylcarbamazine or ivermectin implementation to cover the entire population at risk which is not scaled up to all endemic areas and (ii) alleviating the suffering caused by LF through morbidity management and disability prevention. In Nigeria, the former has gain prominence than the latter. Despite lack of total therapeutic coverage of MDA, high success has been achieved leading to elimination of LF in some states in the country. Availability and resistance of vector species to insecticide govern transmission and sustainability of LF in Nigeria. In view to ensuring a successful control plan and eventual eradication of the disease, in addition to MDA, morbidity management and vector control to prevent human mosquitoes contact should be scale up.
| Anosike, J. C., Nwoke, B. E., Ajayi, E. G., Onwuliri, C. O., Okoro, O. U., Oku, E. E., ... & Meribe, C. O. (2005). Lymphatic filariasis among the Ezza people of Ebonyi state, eastern Nigeria. Annals of Agricultural and Environmental Medicine, 12(2), 181-186. | ||||
| Bockarie, M. J., Pedersen, E. M., White, G. B., & Michael, E. (2009). Role of vector control in the global program to eliminate lymphatic filariasis. Annual Review of Entomology, 54, 469-487. Crossref |
||||
| Celone, M. (2015). Barriers to the elimination of lymphatic filariasis in Sub-Saharan Africa. The Columbia University Journal of Global Health, 5(1), 26-32. | ||||
| Center for Disease Control and Prevention (CDC) (1993). Recommendations of the International Task Force for Disease Eradication. Morbidity Mortality Weekly Report, 42(RR-16), 1-23. Link |
||||
| Chakraborty, S., Gurusamy, M., Zawieja, D. C., & Muthuchamy, M. (2013). Lymphatic filariasis: perspectives on lymphatic remodeling and contractile dysfunction in filarial disease pathogenesis. Microcirculation, 20(5), 349-364. Crossref |
||||
| Conteh, L., Engels, T., & Molyneux, D. H. (2010). Socioeconomic aspects of neglected tropical diseases. The Lancet, 375(9710), 239-247. Crossref |
||||
| Dreyer, G., Norões, J., & Addiss, D. (1997). The silent burden of sexual disability associated with lymphatic filariasis. Acta Tropica, 63, 57-60. Crossref |
||||
| Dzodzomenyo, M., & Simonsen, P. E. (1999). Bancroftian filariasis in an irrigation project community in southern Ghana. Tropical Medicine & International Health, 4(1), 13-18. Crossref |
||||
| Elkanah, O. S., Elkanah, D. S., Wahedi, J. A., Kela, S. L., & Samaila, A. B. (2020). Field Comparison be-tween Blood Immunochromatographic Card Test and Microscopy in Diagnosis of Bancroftian Filariasis in Northern Taraba State, Nigeria. International Journal of Open Access Tropical Diseases, 3, Article Number 042. Crossref |
||||
| Eneanya, O. A., Cano, J., Dorigatti, I., Anagbogu, I., Okoronkwo, C., Garske, T., & Donnelly, C. A. (2018). Environmental suitability for lymphatic filariasis in Nigeria. Parasites & Vectors, 11, Article Number 513. Crossref |
||||
| Evans, D. B., Gelband, H., & Vlassoff, C. (1993). Social and economic factors and the control of lymphatic filariasis: a review. Acta Tropica, 53(1), 1-26. Crossref |
||||
| Famakinde, D. O. (2018). Mosquitoes and the lymphatic filarial parasites: research trends and budding roadmaps to future disease eradication. Tropical Medicine and Infectious Disease, 3, Article Number 4. Crossref |
||||
| Federal Ministry of Health (FMoH) (2019). Nigeria master plan for Neglected Tropical Diseases (NTDs) (2015-2020). Government of the Federal Republic of Nigeria, Abuja. | ||||
| Gyapong, J. O., Owusu, I. O., Vroom, F. B. D. C., Mensah, E. O., & Gyapong, M. (2018). Elimination of lymphatic filariasis: current perspectives on mass drug administration. Research and Reports in Tropical Medicine, 9, 25-33. Crossref |
||||
| Gyapong, M., Gyapong, J., Weiss, M., & Tanner, M. (2000). The burden of hydrocele on men in Northern Ghana. Acta Tropica, 77(3), 287-294. Crossref |
||||
| Hotez, P. J., Asojo, O. A., & Adesina, A. M. (2012). Nigeria: "Ground Zero" for the high prevalence neglected tropical diseases. PLoS Neglected Tropical Diseases, 6(7), e1600. Crossref |
||||
| Hussaini, A., Isaac, C., Rahimat, H., Collins, I., Cedric, O., & Solomon, E. (2020). The Burden of Bancroftian Filariasis in Nigeria: A Review. Ethiopian journal of health sciences, 30(2), 301-310. Crossref |
||||
| Ichimori, K. (2014). MDA-lymphatic filariasis. Journal of Tropical Medicine and Health, 42(2), 21-24. Crossref |
||||
| John, D. T., & William, A. P. Jr. (2006). Medical parasitology. 9th edition. St. Louis, Missouri: Saunders Elsevier. Pp. 274-289. | ||||
| Mackey, T. K., & Liang, B. A. (2012). Lessons from SARS and H1N1/A: employing a WHO-WTO forum to promote optimal economic-public health pandemic response. Journal of Public Health Policy, 33, 119-130. Crossref |
||||
| Mackey, T. K., Liang, B. A., Cuomo, R., Hafen, R., Brouwer, K. C., & Lee, D. E. (2014). Emerging and reemerging neglected tropical diseases: a review of key characteristics, risk factors, and the policy and innovation environment. Clinical Microbiology Reviews, 27(4), 949-979. Crossref |
||||
| Molyneux, D. (2003). Lymphatic filariasis (elephantiasis) elimination: a public health success and development opportunity. Filaria Journal, 2, Article number 13. | ||||
| Mshana, H. J., Baraka, V., Misinzo, G., & Makunde, W. H. (2016). Current epidemiological assessment of bancroftian filariasis in Tanga region, northeastern Tanzania. Journal of Tropical Medicine, Volume 2016, Article ID 7408187, 5 pages. Crossref |
||||
| Nwoke, B. E. B., Nwoke, E. A., Ukaga, C. N., & Nwachukwu, M. I. (2010). Epidemiological characteristics of bancroftian filariasis and the Nigerian environment. Journal of Public Health and Epidemiology, 2(6), 113-117. | ||||
| Obindo, J., Abdulmalik, J., Nwefoh, E., Agbir, M., Nwoga, C., Armiya'u, A., Davou, F., Maigida, K., Otache, E., Ebiloma, A., & Eaton, J. (2017). Prevalence of depression and associated clinical and socio-demographic factors in people living with lymphatic filariasis in Plateau State, Nigeria. PLoS Neglected Tropical Diseases, 11(6), e0005567. Crossref |
||||
| Omedo, M. O., Matey, E. J., Awiti, A., Ogutu, M., Alaii, J., Karanja, D. M., Montgomery, S. P., Secor, W. E., & Mwinzi, P. N. (2012). Community health workers' experiences and perspectives on mass drug administration for schistosomiasis control in western Kenya: the SCORE Project. The American Journal of Tropical Medicine and Hygiene, 87(6), 1065-1072. Crossref |
||||
| Ottesen, E. A., (2000). Editorial: the global programme to eliminate lymphatic filariasis. Journal of Tropical Medicine and International Health, 5(9), 591-594. Crossref |
||||
| Ottesen, E. A., Hooper, P. J., Bradley, M., & Biswas, G. (2008). The global programme to eliminate lymphatic filariasis: health impact after 8 years. PLoS Neglected Tropical Diseases, 2(10), e317. Crossref |
||||
| Ramaiah, K. D., & Kumar, K. V. (2000). Effect of lymphatic filariasis on school children. Acta Tropica, 76(2), 197-199. Crossref |
||||
| Shenoy, R. K. (2008). Clinical and pathological aspects of filarial lymphedema and its management. The Korean Journal of Parasitology, 46(3), 119-125. Crossref |
||||
| Shenoy, R. K., Suma, T. K., Kumaraswami, V., Rahmah, N., Dhananjayan, G., Padma, S., Abhilash, G., & Ramesh, C. (2007). Preliminary findings from a cross-sectional study on lymphatic filariasis in children, in an area of India endemic for Brugia malayi infection. Annals of Tropical Medicine & Parasitology, 101(3), 205-213. Crossref |
||||
| Sogoba, N., Doumbia, S., Vounatsou, P., Baber, I., Keita, M., Maiga, M., & Ribeiro, J. M. C. (2007). Monitoring of larval habitats and mosquito densities in the Sudden Savannah of Mali: Implication for malaria vector control. American Journal of Tropical Medicine and Hygiene, 77(1), 82-88. Crossref |
||||
| The Carter Center (2021). Lymphatic filariasis elimination program. Link |
||||
| Ton, T. G., Mackenzie, C., & Molyneux, D. H. (2015). The burden of mental health in lymphatic filariasis. Infectious Diseases of Poverty, 4, Article number 34. Crossref |
||||
| Ughasi, J., Bekard, H. E., Coulibaly, M., Adabie-Gomez, D., Gyapong, J., Appawu, M., Wilson, M. D., & Boakye, D. A. (2012). Mansonia africana and Mansonia uniformis are vectors in the transmission of Wuchereria bancrofti lymphatic filariasis in Ghana. Parasites & Vectors, 5, Article number 89. Crossref |
||||
| Witt, C., & Ottesen, E. A. (2001). Lymphatic filariasis: an infection of childhood. Tropical Medicine & International Health, 6(8), 582-606. Crossref |
||||
| World Health Organization (WHO) (2010). Progress report 2000-2009 and strategic plan 2010-2020 of the global programme to eliminate lymphatic filariasis: halfway towards eliminating lymphatic filariasis. Link |
||||
| World Health Organization (WHO) (2011). Monitoring and epidemiological assessment of mass drug administration in globalprogramme to eliminate lymphatic filariasis: A manual for national elimination programmes. Geneva: World Health Organization. | ||||
| World Health Organization (WHO) (2012). Lymphatic filariasis [Fact Sheet]. Link |
||||
| World Health Organization (WHO) (2013). Global programme to eliminate lymphatic filariasis. A Handbook of practical entomology for national lymphatic filariasis elimination programmes. | ||||
| World Health Organization (WHO) (2014). Fact sheet, lymphatic filariasis world health day 2014. Link |
||||
| World Health Organization (WHO) (2017). Expanded special project for elimination of neglected tropical disease. Link |
||||
| World Health Organization (WHO) (2019). Lymphatic filariasis fact sheet. Retrieved from www.WHO.int/news-room/fact-sheet/detail/lymphatic-filariasis. | ||||
| Wynd, S., Melrose, W. D., Durrheim, D. N., Carron, J., & Gyapong, M. (2007). Understanding the community impact of lymphatic filariasis: a review of the sociocultural literature. Bulletin of the World Health Organization, 85(6), 493-498. Crossref |
||||